Pier 88 Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pier 88 Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237K	Buy	1,500 +400	+36%	+$54.1K	0.06%	87
2026 Q1	$141K	Hold	1,100	–	–	0.04%	109
2025 Q4	$134K	Buy	1,100 +500	+83%	+$57.3K	0.03%	112
2025 Q3	$60.1K	Buy	+600	New	+$54K	0.01%	111
2024 Q4	–	Sell	-2,500	Closed	-$247K	–	102
2024 Q3	$247K	Buy	+2,500	New	+$246K	0.05%	87

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Pier 88 Investment Partners's XBI Position: Q2 2026 in Review

Pier 88 Investment Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 36% in Q2 2026, buying an estimated $54.1K and bringing the position to 1,500 shares worth $237K. The position accounts for 0.06% of the portfolio, ranked #87.

Pier 88 Investment Partners first reported a position in XBI in Q3 2024 and has held it in 5 quarters since. The position peaked at $247K in Q3 2024. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Pier 88 Investment Partners held 1,500 shares of State Street SPDR S&P Biotech ETF worth $237K as of Q2 2026.
Pier 88 Investment Partners bought 400 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $54.1K.
State Street SPDR S&P Biotech ETF made up 0.06% of Pier 88 Investment Partners's portfolio in Q2 2026, its #87 holding.
Pier 88 Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 5 quarters since.
Pier 88 Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $247K in Q3 2024.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pier 88 Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.